GlassScriptPhysician profile
Richard Natale
NPI 1700957677
$107,876.21
in general payments reported to CMS, 2019-2025
23 companies · $15K in 2025
The $15K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $19K · 2021: $6,908 · 2022: $23K · 2023: $6,472 · 2024: $18K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Travel and Lodging: $4,663 · Consulting Fee: $2,850 · Food and Beverage: $2,791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,100.00 |
| Travel and Lodging | $4,662.63 |
| Consulting Fee | $2,850.00 |
| Food and Beverage | $2,791.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $97,344.70 | 2019-2025 | Advance Xp, General - Erectile Dysfunction, Ams 700 Cxr Rte Kit |
| Dendreon Pharmaceuticals LLC | $2,110.23 | 2019-2021 | |
| Axonics, INC. | $1,921.06 | 2023-2024 | Axonics, Bulkamid |
| Janssen Scientific Affairs, LLC | $1,767.50 | 2021-2022 | |
| Medtronic USA, INC. | $1,497.92 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $1,195.47 | 2019-2020 | |
| Procept Biorobotics Corporation | $1,110.37 | 2019 | |
| Astellas Pharma US INC | $202.33 | 2019 | |
| Endo Pharmaceuticals INC. | $123.50 | 2019 | |
| Janssen Biotech, INC. | $97.69 | 2019 | |
| Tolmar, INC. | $91.29 | 2023-2024 | |
| Medtronic, INC. | $75.13 | 2022-2024 | Interstim, Nuro |
| Neotract INC. | $58.17 | 2019 | |
| Laborie Medical Technologies Corp. | $43.40 | 2021-2024 | Endosheath Technology |
| Antares Pharma, INC. | $41.71 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $40.59 | 2019 | |
| Peerless Surgical INC. | $40.12 | 2023 | |
| Ethicon US, LLC | $28.44 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.45 | 2019 | |
| Sun Pharmaceutical Industries INC. | $19.24 | 2019 | |
| 180 Medical, INC. | $18.52 | 2019 | |
| Coloplast Corp | $15.31 | 2025 | |
| Merck Sharp & Dohme LLC | $14.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Natale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.